 | AstraZeneca Recommends Shareholders Reject TRC Capital Mini-Tender Bid - MarketWatch
marketwatch.com - October 18 at 8:38 AM |
| Pfizer and AstraZeneca vaccines were as effective as prior infection, U.K. study finds - MarketWatch
marketwatch.com - October 18 at 8:38 AM |
| Valneva shares spike after saying vaccine candidate outperformed AstraZeneca's - MarketWatch
marketwatch.com - October 18 at 8:38 AM |
 | Valneva Soars as Covid Vaccine Candidate Shows Promise
finance.yahoo.com - October 18 at 8:38 AM |
| Valneva shares jump 30% after saying vaccine candidate outperformed AstraZeneca's
finance.yahoo.com - October 18 at 8:38 AM |
| Thailand to cease Sinovac vaccine use when stocks end this month
finance.yahoo.com - October 18 at 8:38 AM |
| Pfizer and AstraZeneca vaccines were as effective as prior infection, U.K. study finds
finance.yahoo.com - October 18 at 8:38 AM |
 | Valneva Covid jab produces stronger immune response than AstraZeneca vaccine - Financial Times
ft.com - October 18 at 3:37 AM |
 | AstraZeneca Recommends Shareholders Reject TRC Capital's Mini-Tender Offer - Quick Facts - Nasdaq
nasdaq.com - October 18 at 3:37 AM |
 | AstraZeneca Recommends Shareholders Reject TRC Capital's Mini-Tender Offer - Quick Facts
markets.businessinsider.com - October 18 at 3:29 AM |
|
| UPDATE 1-U.S. will accept mixed doses of vaccines from international travelers
finance.yahoo.com - October 15 at 7:54 PM |
 | AstraZeneca Wins Ruling Upholding Key Patent for Diabetes Drug - Bloomberg
bloomberg.com - October 15 at 6:41 PM |
| AstraZeneca Reports Positive Results in Liver Cancer Drug Trial - Bloomberg
bloomberg.com - October 15 at 1:38 PM |
| Don’t Count Out Covid-19 Monoclonal Antibody Treatments, Analyst Says. These Are the Stocks to Watch.
finance.yahoo.com - October 15 at 1:38 PM |
| AZN : Imfinzi Plus Tremelimumab Improves OS In Phase III Trial In Liver Cancer
markets.businessinsider.com - October 15 at 8:37 AM |
| AstraZeneca Says Combination of Tremelimumab and Imfinzi Antibodies Boosted Liver Cancer Survival - MarketWatch
marketwatch.com - October 15 at 3:37 AM |
| Doctor on Covid-19: ‘Let history guide our future actions’
finance.yahoo.com - October 14 at 2:47 PM |
| Here's Why Astrazeneca (AZN) is a Strong Momentum Stock
finance.yahoo.com - October 14 at 12:35 PM |
| Australia's CSL reiterates manufacturing commitment with AstraZeneca COVID-19 vaccine - Yahoo Finance
finance.yahoo.com - October 14 at 7:35 AM |
| AstraZeneca and Columbia University Irving Medical Center on Lessons Learned From the Pandemic - Bloomberg
bloomberg.com - October 13 at 3:54 PM |
 | AstraZeneca COVID-19 jab will no longer be made in Australia - 9News - Seeking Alpha
seekingalpha.com - October 13 at 3:54 PM |
| UPDATE 1-Russia says Sputnik Light is 70% effective against Delta variant
finance.yahoo.com - October 13 at 2:14 PM |
 | Russia furiously denies stealing AstraZeneca ‘blueprint’ to make Sputnik V COVID-19 vaccine - Fortune
fortune.com - October 12 at 4:13 AM |
 | S.Korea to donate 1.1 mln doses of AstraZeneca COVID-19 vaccine to Vietnam, 470000 doses to Thailand - Reuters
reuters.com - October 12 at 4:13 AM |
| 4 Biotech Stocks To Watch As AstraZeneca Posts COVID Antibody Cocktail Breakthrough - Nasdaq
nasdaq.com - October 12 at 1:14 AM |
 | AstraZeneca's (AZN) Buy Rating Reaffirmed at Deutsche Bank Aktiengesellschaft
americanbankingnews.com - October 11 at 4:16 PM |
| Merck Stock Slips Slightly As It Asks FDA To Authorize Covid Pill
finance.yahoo.com - October 11 at 3:14 PM |
| Merck seeks authorization for what would be first pill to treat COVID-19, and AstraZeneca reports positive results for antibody treatment
finance.yahoo.com - October 11 at 12:39 PM |
 | AstraZeneca antibody drug cuts severe COVID-19 by 50%: study - Business Insider
businessinsider.com - October 11 at 10:14 AM |
| AstraZeneca Says Drug Reduces Risk of Developing Severe Covid by 50%
finance.yahoo.com - October 11 at 10:14 AM |
| AstraZeneca antibody cocktail succeeds in late-stage study to treat COVID-19 - Reuters
reuters.com - October 11 at 7:39 AM |
| AstraZeneca Says Drug Cocktail Effective in Reducing Risk of Developing Severe Covid-19
finance.yahoo.com - October 11 at 7:39 AM |
|
| AstraZeneca's AZD7442 Trial Showed Reduced Risk of Developing Severe Covid-19 - MarketWatch
marketwatch.com - October 11 at 2:38 AM |
| Costa Rica government unveils migrant COVID-19 vaccination campaign
finance.yahoo.com - October 8 at 11:28 PM |
| 10 Stocks to Buy in 2021 According to Carl Tiedemann’s TIG Advisors
finance.yahoo.com - October 8 at 8:42 AM |
| AstraZeneca: Tezepelumab Gets FDA Orphan Designation for Eosinophilic Esophagitis - MarketWatch
marketwatch.com - October 8 at 8:23 AM |
| Tezepelumab granted Orphan Drug Designation in the US for eosinophilic esophagitis
finance.yahoo.com - October 8 at 8:23 AM |
| AstraZeneca's experimental asthma gets an orphan drug designation for another disease
finance.yahoo.com - October 8 at 8:23 AM |
| November 26th Options Now Available For AstraZeneca (AZN) - Nasdaq
nasdaq.com - October 7 at 7:48 PM |
| Booster discussion 'a bit convoluted': Doctor
finance.yahoo.com - October 7 at 7:30 PM |
| Mixing & matching covid boosters ‘might be a great opportunity’: Doctor
finance.yahoo.com - October 6 at 4:42 PM |
| Fortress Biotech Announces Closing of Acquisition of Caelum Biosciences by AstraZeneca - Yahoo Finance
finance.yahoo.com - October 6 at 11:09 AM |
| AstraZeneca Requests US FDA Emergency Use Authorization for Covid-19 Prophylaxis - MarketWatch
marketwatch.com - October 6 at 4:58 AM |
| AstraZeneca (AZN) Seeks Emergency Nod for COVID Prevention Drug
finance.yahoo.com - October 6 at 4:58 AM |
| 'If you’re not vaccinated, get vaccinated': Doctor
finance.yahoo.com - October 6 at 4:58 AM |
| AstraZeneca Seeks U.S. Emergency Approval for Covid Antibody - Bloomberg
bloomberg.com - October 5 at 4:18 AM |
| Financial, travel stocks weigh on FTSE 100; Morrisons drops - Reuters
reuters.com - October 4 at 12:42 PM |
| AstraZeneca's Enhertu Receives Fourth U.S. Breakthrough Therapy Designation - Nasdaq
nasdaq.com - October 4 at 8:15 AM |
| Compugen Announces Milestone Payment from AstraZeneca Triggered by First Patient Dosed with TIGIT Bispecific Derived from COM902 - Yahoo Finance
finance.yahoo.com - October 4 at 7:42 AM |
| Oil stocks, AstraZeneca support FTSE 100; Morrisons drops - Reuters
reuters.com - October 4 at 7:42 AM |
